Jupiter Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
Jupiter Asset Management's LGND Position: Q3 2026 in Review
Jupiter Asset Management held its Ligand Pharmaceuticals (LGND) position steady in Q3 2026 at 736 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #528.
Jupiter Asset Management first reported a position in LGND in Q4 2020 and has held it in 16 quarters since. The position peaked at $2.93M in Q4 2020. 434 funds tracked by Wall St. Rank hold LGND as of Q3 2026.
- Jupiter Asset Management held 736 shares of Ligand Pharmaceuticals worth $230K as of Q3 2026.
- Jupiter Asset Management left its Ligand Pharmaceuticals share count unchanged in Q3 2026.
- Ligand Pharmaceuticals made up ﹤0.01% of Jupiter Asset Management's portfolio in Q3 2026, its #528 holding.
- Jupiter Asset Management first reported a position in Ligand Pharmaceuticals in Q4 2020 and has held it in 16 quarters since.
- Jupiter Asset Management's Ligand Pharmaceuticals position peaked at $2.93M in Q4 2020.
- 434 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.
Based on Jupiter Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.